Verified earnings results
Nurix Therapeutics Q3 2026 Earnings Results
Direct answer
Nurix Therapeutics reported Q3 2026 results on October 12, 2026.
Revenue was 673,064,000. EPS beat the estimate by 871.74%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- October 12, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.6129
- Reported EPS
- 4.73
- Revenue
- 673,064,000
- EPS surprise
- EPS beat the estimate by 871.74%.
Explore related company data
Read the frequently asked questions.
When did Nurix Therapeutics report Q3 2026 earnings?
Nurix Therapeutics reported on October 12, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Nurix Therapeutics?
The verified record provides an EPS estimate of -0.6129.
Has Nurix Therapeutics reported the Q3 2026 result?
Revenue was 673,064,000. EPS beat the estimate by 871.74%.
Which source supports this Nurix Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.